Barton P. Bandy, President and CEO at ReShape Lifesciences Inc. (RSLS), sold 588,988 shares at $2.89 ($1.7M) on 2021-09-10, disclosed to the SEC on 2021-09-17.
Open-market sale of $1.7M RSLS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.89 | 294,494 | $851K | 50.0% |
| 2 | $2.89 | 294,494 | $851K | 50.0% |
| Total | $2.89 avg | 588,988 | $1.7M | 100% |
| Filing → |
| RSLS | SELL | 2022-06-06 | $11K | — | Filing → |
| RSLS | SELL | 2022-05-12 | $9K | — | Filing → |
| RSLS | SELL | 2022-04-08 | $13K | — | Filing → |